{"id":13592,"date":"2025-08-14T17:45:03","date_gmt":"2025-08-14T12:15:03","guid":{"rendered":"https:\/\/trending.niftytrader.in\/?p=13592"},"modified":"2025-08-14T17:51:30","modified_gmt":"2025-08-14T12:21:30","slug":"glenmark-pharma-q1-fy26-profit-down","status":"publish","type":"post","link":"https:\/\/www.niftytrader.in\/markets\/glenmark-pharma-q1-fy26-profit-down\/","title":{"rendered":"Glenmark Pharma Q1 FY26 Results: Sharp Profit Decline, Modest Revenue Growth"},"content":{"rendered":"<p data-start=\"374\" data-end=\"573\">Glenmark Pharmaceuticals announced its Q1 results for the April\u2013June quarter of financial year 2026, reporting a steep 86% fall in net profit to \u20b947 crore compared to the same period last year.<\/p>\n<p data-start=\"575\" data-end=\"740\">Despite the sharp drop in profitability, the company\u2019s revenue saw a marginal increase, reflecting steady sales performance amid challenging market conditions.<\/p>\n<h2 data-start=\"747\" data-end=\"782\">Part of a Busy Earnings Season<\/h2>\n<p data-start=\"784\" data-end=\"1166\">The announcement comes during an active earnings season, with nearly 665 companies set to release their April\u2013June quarter results. Alongside Glenmark, other notable names reporting include Vodafone Idea (Vi), Indian Oil Corporation (IOC), Ashok Leyland, AstraZeneca Pharma, Coffee Day Enterprises, Easy Trip Planners, GKB Ophthalmics, Inox Wind, Patanjali Foods, and Sanstar.<\/p>\n<p>Also Read: <a href=\"https:\/\/www.niftytrader.in\/content\/proposed-h1b-rule-change-impact-indian-it\/\">Proposed H-1B Rule Change Could Alter Indian IT Hiring Landscape<\/a><\/p>\n<h3 data-start=\"1173\" data-end=\"1217\">Market Focus on Profitability Pressures<\/h3>\n<p data-start=\"1219\" data-end=\"1474\">While revenue growth remained slightly positive, the sharp fall in net profit indicates possible cost pressures or lower margins for the company. Investors will be closely watching Glenmark\u2019s upcoming quarters for signs of recovery in profitability.<\/p>\n<p><i>Click here to explore: <a href=\"https:\/\/www.niftytrader.in\/stocks-price\/glenmark\">Glenmark Pharma<\/a><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals announced its Q1 results for the April\u2013June quarter of financial year 2026, reporting a steep 86% fall in net profit to \u20b947 crore compared to the same period last year. Despite the sharp drop in profitability, the company\u2019s revenue saw a marginal increase, reflecting steady sales performance amid challenging market conditions. Part of [&hellip;]<\/p>\n","protected":false},"author":10,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[615],"tags":[],"ppma_author":[1386],"class_list":{"0":"post-13592","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-stock-market-news"}," _eael_post_view_count":0,"authors":[{"term_id":1386,"user_id":10,"is_guest":0,"slug":"ruchikadave","display_name":"Ruchika Dave","avatar_url":{"url":"https:\/\/trending.niftytrader.in\/wp-content\/uploads\/2025\/07\/Ruchika-Dave.jpg","url2x":"https:\/\/trending.niftytrader.in\/wp-content\/uploads\/2025\/07\/Ruchika-Dave.jpg"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":""}],"_links":{"self":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/13592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/comments?post=13592"}],"version-history":[{"count":2,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/13592\/revisions"}],"predecessor-version":[{"id":13595,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/13592\/revisions\/13595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media\/13593"}],"wp:attachment":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media?parent=13592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/categories?post=13592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/tags?post=13592"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/ppma_author?post=13592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}